Pesorimcovatein

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 19:30:51 GMT 2025` Edited by `admin` on `Wed Apr 02 19:30:51 GMT 2025`
Protein Sub Type
Record UNII	Q3TKB7GHJ4
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

1-1190-Viral spike glycoprotein [663-proline,664-glycine,665-serine,667-serine,799-proline,874-proline,881-proline,924-proline,968-proline,969-proline] (severe acute respiratory syndrome coronavirus 2 strain BQ.1.1) fusion protein with 458-484-fibritin (

Preferred Name

English

Pesorimcovatein

Official Name

English

pesorimcovatein [INN]

Common Name

English

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), omicron lineage BQ.1.1.1 (Gisaid: EPI_ISL_14752457) spike (S) glycoprotein fragment (1-1190), stable prefusion conformation variant (H<sup>663</sup>>P, R<sup>664</sup>>G, R<sup>665</sup>>S, R<

Common Name

English

Code System Code Type Description

CAS

2923542-42-9

Created by admin on Wed Apr 02 19:30:51 GMT 2025 , Edited by admin on Wed Apr 02 19:30:51 GMT 2025

PRIMARY

FDA UNII

Q3TKB7GHJ4

Created by admin on Wed Apr 02 19:30:51 GMT 2025 , Edited by admin on Wed Apr 02 19:30:51 GMT 2025

PRIMARY

SMS_ID

300000050489

Created by admin on Wed Apr 02 19:30:51 GMT 2025 , Edited by admin on Wed Apr 02 19:30:51 GMT 2025

PRIMARY

INN

13196

Created by admin on Wed Apr 02 19:30:51 GMT 2025 , Edited by admin on Wed Apr 02 19:30:51 GMT 2025

PRIMARY

NCI_THESAURUS

C206966

Created by admin on Wed Apr 02 19:30:51 GMT 2025 , Edited by admin on Wed Apr 02 19:30:51 GMT 2025

PRIMARY

From	To
1_1064	1_1108
3_1064	3_1108
2_1064	2_1108
1_1014	1_1025
3_1014	3_1025
2_1014	2_1025
1_822	1_833
3_822	3_833
2_822	2_833
1_725	1_731
3_725	3_731
2_725	2_731
1_720	1_742
3_720	3_742
2_720	2_742
1_644	1_653
3_644	3_653
2_644	2_653
1_599	1_631
3_599	3_631
2_599	2_631
1_520	1_572
3_520	3_572
2_520	2_572
1_462	1_470
3_462	3_470
2_462	2_470
1_373	1_507
3_373	3_507
2_373	2_507
1_361	1_414
3_361	3_414
2_361	2_414
1_318	1_343
3_318	3_343
2_318	2_343
1_273	1_283
3_273	3_283
2_273	2_283
1_118	1_148
3_118	3_148
2_118	2_148
1_2	1_113
3_2	3_113
2_2	2_113

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_45
N	1_56
N	1_104
N	1_131
N	1_147
N	1_216
N	1_264
N	1_313
N	1_325
N	1_585
N	1_598
N	1_639
N	1_691
N	1_699
N	1_783
N	1_1056
N	1_1080
N	1_1116
N	1_1140
N	1_1155
N	1_1176
N	2_45
N	2_56
N	2_104
N	2_131
N	2_147
N	2_216
N	2_264
N	2_313
N	2_325
N	2_585
N	2_598
N	2_639
N	2_691
N	2_699
N	2_783
N	2_1056
N	2_1080
N	2_1116
N	2_1140
N	2_1155
N	2_1176
N	3_45
N	3_56
N	3_104
N	3_131
N	3_147
N	3_216
N	3_264
N	3_313
N	3_325
N	3_585
N	3_598
N	3_639
N	3_691
N	3_699
N	3_783
N	3_1056
N	3_1080
N	3_1116
N	3_1140
N	3_1155
N	3_1176

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Amount:

Related Record Type Details


					Q3TKB7GHJ4

Pesorimcovatein

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL